Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson's disease.

Celorrio, Marta

Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson's disease. [electronic resource] - Brain, behavior, and immunity Oct 2016 - 94-105 p. digital

Publication Type: Journal Article

1090-2139

10.1016/j.bbi.2016.06.010 doi


Amidohydrolases--antagonists & inhibitors
Animals
Arachidonic Acids--metabolism
Benzamides--administration & dosage
Cannabinoid Receptor Agonists--metabolism
Carbamates--administration & dosage
Disease Models, Animal
Endocannabinoids--metabolism
Male
Mice
Mice, Inbred C57BL
Parkinsonian Disorders--drug therapy
Polyunsaturated Alkamides--metabolism
Receptor, Cannabinoid, CB1--antagonists & inhibitors
Receptor, Cannabinoid, CB2--antagonists & inhibitors